WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
JAMP PHARMA CORPORATION
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE in Canada?
Yes. WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE 300MG 8MG 15MG has an active shortage reported to Health Canada (last updated March 1, 2019).
Why is WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE be available again?
The estimated resolution date (December 31, 2020) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02453703
Strength
300MG 8MG 15MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164